Minimal residual disease (MRD) assessment before and after autologous hematopoietic cell transplantation (AutoHCT) and maintenance for multiple myeloma (MM): Results of the prognostic immunophenotyping for myeloma response (PRIMeR) study Meeting Abstract


Authors: Hahn, T. E.; Wallace, P. K.; Fraser, R.; Fei, M.; Tario, J. D.; Howard, A.; Zhang, Y.; Blackwell, B.; Brunstein, C. G.; Efebera, Y. A.; Geller, N.; Giralt, S. A.; Hari, P.; Knust, K.; Koreth, J.; Krishnan, A.; Landau, H.; Shah, N.; Somlo, G.; Stadtmauer, E. A.; Vogl, D. T.; Vesole, D. H.; McCarthy, P. L.; Pasquini, M. C.
Abstract Title: Minimal residual disease (MRD) assessment before and after autologous hematopoietic cell transplantation (AutoHCT) and maintenance for multiple myeloma (MM): Results of the prognostic immunophenotyping for myeloma response (PRIMeR) study
Meeting Title: 2019 TCT Meetings of ASBMT and CIBMTR
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 25
Issue: 3 Suppl.
Meeting Dates: 2019 Feb 20-24
Meeting Location: Houston, TX
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2019-03-01
Start Page: S4
End Page: S5
Language: English
ACCESSION: WOS:000540655500007
PROVIDER: wos
DOI: 10.1016/j.bbmt.2018.12.687
Notes: Meeting Abstract: 6 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1051 Giralt
  2. Heather Jolie Landau
    419 Landau
Related MSK Work